NYSE · Healthcare

Concord Medical Services Holdings Ltd (CCM)

As-reported financials and recent SEC filings for Concord Medical Services Holdings Ltd, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$454.3M

Net income

$-92.8M

Net margin

-20.4%

Diluted EPS

$-0.71

ROE

-5.0%

P/E (TTM)

—

Market cap

—

Debt / equity

1.3×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$454.3M	$374.6M	$520.7M	$450.1M	$443.1M
Gross profit	$19.6M	$-88.5M	$-93.3M	$-174.4M	$-99.4M
Operating income	$-261.5M	$-532.2M	$-463.0M	$-525.0M	$-458.3M
Net income	$-92.8M	$-308.2M	$-297.7M	$-489.7M	$-271.4M
Diluted EPS	$-0.71	$-2.35	$-2.27	$-3.74	$-6.26

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

6-K2026-07-02

6-K2026-05-18

6-K2026-05-13

6-K2026-05-13

20-F2026-04-29

6-K2026-04-15

32026-03-18

32026-03-18

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on CCM

Search Concord Medical Services Holdings Ltd’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.